Olmesartan Medoxomil
NDC 67877-446, Olmesartan Medoxomil, tablet, coated, from Ascend Laboratories, LLC.
- Product NDC
- 67877-446
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206763
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-446 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLMESARTAN MEDOXOMIL20 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-446-05 | 67877044605 | 500 TABLET, COATED in 1 BOTTLE (67877-446-05) |
| 67877-446-10 | 67877044610 | 1000 TABLET, COATED in 1 BOTTLE (67877-446-10) |
| 67877-446-30 | 67877044630 | 30 TABLET, COATED in 1 BOTTLE (67877-446-30) |
| 67877-446-33 | 67877044633 | 1 BLISTER PACK in 1 CARTON (67877-446-33) / 10 TABLET, COATED in 1 BLISTER PACK |
| 67877-446-38 | 67877044638 | 10 BLISTER PACK in 1 CARTON (67877-446-38) / 10 TABLET, COATED in 1 BLISTER PACK |
| 67877-446-74 | 67877044674 | 5 BLISTER PACK in 1 CARTON (67877-446-74) / 10 TABLET, COATED in 1 BLISTER PACK |
| 67877-446-84 | 67877044684 | 3 BLISTER PACK in 1 CARTON (67877-446-84) / 10 TABLET, COATED in 1 BLISTER PACK |
| 67877-446-90 | 67877044690 | 90 TABLET, COATED in 1 BOTTLE (67877-446-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/142b735a-e1cd-46e1-a523-3ef061001bf9NADAC price for package 67877044630
GET /v1/drugs/nadac/67877044630NADAC price for package 67877044690
GET /v1/drugs/nadac/67877044690
Use it
Look up 67877-446 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-446 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-446. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.